9/22/2026
NIH funds ibogaine study for opioid addiction with heart safety focus
Brigham and Women's Hospital receives $2.3 million to assess ibogaine's safety for opioid use disorder.
Topic archive
arpa h
2 stories
9/1/2026
ARPA-H backs ibogaine research amid rising pharma ad spend
Pharmaceutical companies increase ad budgets for psychedelic terms as ARPA-H funds ibogaine studies.